QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, January 12, 2005, 25(2):299-307; doi:10.1523/JNEUROSCI.2544-04.2005

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (61) Citing Articles via Google Scholar Google Scholar Articles by Cordle, A. Articles by Landreth, G. Search for Related Content PubMed PubMed Citation Articles by Cordle, A. Articles by Landreth, G.

 Previous Article  |  Next Article 

Neurobiology of Disease
3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors Attenuate -Amyloid-Induced Microglial Inflammatory Responses

Andrew Cordle and Gary Landreth

Alzheimer Research Laboratory, Department of Neurosciences, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106

Alzheimer's disease (AD) is characterized by extracellular deposits of fibrillar -amyloid (A) in the brain, a fulminant microglial-mediated inflammatory reaction, and neuronal death. The use of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) is associated with a reduced risk of AD, which has been attributed to the cholesterol-lowering actions of these drugs. Statins have been reported recently to have anti-inflammatory actions in addition to their classic lipid-lowering effects. We report that statins robustly inhibited the A-stimulated expression of interleukin-1 and inducible nitric oxide synthase and the production of nitric oxide by microglia and monocytes. Statin treatment also blocked the rac1-dependent activation of NADPH oxidase and superoxide production. The anti-inflammatory actions of the statins were attributable to their ability to reduce the levels of isoprenyl intermediates in the cholesterol biosynthetic pathway. The effect of statins could not be reversed by exogenous cholesterol supplementation, indicating that the anti-inflammatory actions are distinct from their cholesterol-lowering actions. The addition of the isoprenyl precursors, mevalonic acid, and geranylgeranyl pyrophosphate (GGpp) attenuated the statin-mediated downregulation of inflammatory markers. Prevention of protein isoprenylation by the GGpp transferase inhibitor (GGTI-286) or inhibition of Rho-family function with Clostridium difficile Toxin A blocked the inflammatory response similar to the effect of statin treatment. We argue that the statin-mediated decrease in AD risk arises from their pleiotropic actions, effecting a reduction in neuronal A production and microglia-directed inflammation.

Key words: Alzheimer; -amyloid; inflammation; HMG-CoA reductase inhibitor; microglia; NSAIDs

---

Received June 25, 2004; revised November 16, 2004; accepted November 18, 2004.

This article has been cited by other articles:

				H. W. Querfurth and F. M. LaFerla Alzheimer's Disease N. Engl. J. Med., January 28, 2010; 362(4): 329 - 344. [Full Text] [PDF]

				A. S. Paintlia, M. K. Paintlia, A. K. Singh, and I. Singh Inhibition of Rho Family Functions by Lovastatin Promotes Myelin Repair in Ameliorating Experimental Autoimmune Encephalomyelitis Mol. Pharmacol., May 1, 2008; 73(5): 1381 - 1393. [Abstract] [Full Text] [PDF]

				S. M. Ostrowski, B. L. Wilkinson, T. E. Golde, and G. Landreth Statins Reduce Amyloid-beta Production through Inhibition of Protein Isoprenylation J. Biol. Chem., September 14, 2007; 282(37): 26832 - 26844. [Abstract] [Full Text] [PDF]

				S. J. Lee, H. Qin, and E. N. Benveniste Simvastatin inhibits IFN-{gamma}-induced CD40 gene expression by suppressing STAT-1{alpha} J. Leukoc. Biol., August 1, 2007; 82(2): 436 - 447. [Abstract] [Full Text] [PDF]

				C. L. Masters and K. Beyreuther Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the A{beta} amyloid pathway Brain, November 1, 2006; 129(11): 2823 - 2839. [Abstract] [Full Text] [PDF]

				A. Cordle, J. Koenigsknecht-Talboo, B. Wilkinson, A. Limpert, and G. Landreth Mechanisms of Statin-mediated Inhibition of Small G-protein Function J. Biol. Chem., October 7, 2005; 280(40): 34202 - 34209. [Abstract] [Full Text] [PDF]

				R. M. Lane and M. R. Farlow Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease J. Lipid Res., May 1, 2005; 46(5): 949 - 968. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help